Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma

Oral Oncology

Volumn 47, Issue 12, 2011, Pages 1148-1153

  Cho, Young Ah ^a   Yoon, Hye Jung ^a   Lee, Jae Il ^a   Hong, Sam Pyo ^a   Hong, Seong Doo ^a  

^a Seoul National University   (South Korea)

Author keywords

Cancer immunity; CD8 + lymphocytes; Oral squamous cell carcinoma; PD L1; Tumor associated fibroblasts; Tumor infiltrating lymphocytes

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1;

ADULT; ARTICLE; CANCER STAGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME;

ANTIGENS, CD274; CARCINOMA, SQUAMOUS CELL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FIBROBLASTS; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS;

EID: 82255179501     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.08.007     Document Type: Article

References (20)

1. R. Uppaluri, G.P. Dunn, and J.S. Lewis Jr Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers Cancer Immun 8 2008 16
2. G.A. Rabinovich, D. Gabrilovich, and E.M. Sotomayor Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 25 2007 267 296 (Pubitemid 46697910)
3. Y. Watanabe, F. Katou, H. Ohtani, T. Nakayama, O. Yoshie, and K. Hashimoto Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109 5 2010 744 752
4. H. Ghebeh, S. Mohammed, A. Al-Omair, A. Qattan, C. Lehe, and G. Al-Qudaihi The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors Neoplasia 8 3 2006 190 198 (Pubitemid 43671234)
5. R.H. Thompson, M.D. Gillett, J.C. Cheville, C.M. Lohse, H. Dong, and W.S. Webster Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma Cancer 104 10 2005 2084 2091 (Pubitemid 41579953)
6. F. Tsushima, K. Tanaka, N. Otsuki, P. Youngnak, H. Iwai, and K. Omura Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma Oral Oncol 42 3 2006 268 274 (Pubitemid 43246758)
7. M.R. Nazareth, L. Broderick, M.R. Simpson-Abelson, R.J. Kelleher Jr, S.J. Yokota, and R.B. Bankert Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells J Immunol 178 9 2007 5552 5562 (Pubitemid 46674350)
8. J.L. Barnas, M.R. Simpson-Abelson, S.J. Yokota, R.J. Kelleher, and R.B. Bankert T cells and stromal fibroblasts in human tumor microenvironments represent potential therapeutic targets Cancer Microenviron 3 1 2010 29 47
9. H. Kitano, S. Kageyama, S.M. Hewitt, R. Hayashi, Y. Doki, and Y. Ozaki Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival Arch Pathol Lab Med 134 10 2010 1520 1527
10. S.E. Strome, H. Dong, H. Tamura, S.G. Voss, D.B. Flies, and K. Tamada B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma Cancer Res 63 19 2003 6501 6505 (Pubitemid 37255203)
11. X. Zhang, and S.E. Strome B7-H1-targeted immunotherapy for head and neck cancer Expert Opin Biol Ther 4 10 2004 1577 1583 (Pubitemid 39371753)
12. H. Dong, S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, and D.B. Flies Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion Nat Med 8 8 2002 793 800
13. Y. Ye, L. Zhou, X. Xie, G. Jiang, H. Xie, and S. Zheng Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion J Surg Oncol 100 6 2009 500 504
14. N.L. Costa, C. Alencar Rde, M.C. Valadares, T.A. Silva, E.F. Mendona, and A.C. Batista The clinicopathological significance of the expression of Granzyme B in oral squamous cell carcinoma Oral Oncol 46 3 2010 185 189
15. C. Badoual, S. Hans, J. Rodriguez, S. Peyrard, C. Klein, and H. Agueznay Nel Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers Clin Cancer Res 12 2 2006 465 472 (Pubitemid 43166137)
16. R.H. Straub The complex role of estrogens in inflammation Endocr Rev 28 5 2007 521 574 (Pubitemid 47236336)
17. J. Nakanishi, Y. Wada, K. Matsumoto, M. Azuma, K. Kikuchi, and S. Ueda Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers Cancer Immunol Immunother 56 8 2007 1173 1182 (Pubitemid 46763932)
18. R. Karim, E.S. Jordanova, S.J. Piersma, G.G. Kenter, L. Chen, and J.M. Boer Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma Clin Cancer Res 15 20 2009 6341 6347
19. J. Konishi, K. Yamazaki, M. Azuma, I. Kinoshita, H. Dosaka-Akita, and M. Nishimura B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression Clin Cancer Res 10 15 2004 5094 5100 (Pubitemid 39106851)
20. H. Ghebeh, C. Lehe, E. Barhoush, K. Al-Romaih, A. Tulbah, and M. Al-Alwan Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule Breast Cancer Res 12 4 2010 R48